CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
Author
A Stein
Bengt Glimelius
+50Â more
BJ Giantonio
C Allegra
C Kenis
Camilla Qvortrup
D Cunningham
D Podsiadlo
D Saliba
E Cutsem Van
G Folprecht
G Pentheroudakis
H Sorbye
H Sorbye
H Sorbye
H Sorbye
H Sorbye
H Wildiers
Halfdan Sorbye
HK Sanoff
K Muro
KS Scher
L Decoster
L Min
L Mol
M Ducreux
M Extermann
M Koopman
M Yoshida
MT Seymour
MT Seymour
P Pfeiffer
P Thirion
Per Pfeiffer
Pia Österlund
R Mahlberg
S Braendegaard Winther
S Venderbosch
SB Winther
SM Alibhai
Stine Braendegaard Winther
T Aparicio
T Aparicio
T Landre
T Lembrecht Jorgensen
T McKibbin
TJ Price
VE Lemmens
Y Tomita
Y Yamada
YS Hong
Ã…ke Berglund
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Full text link
Crossref